GB201406986D0 - Bicyclic heterocycle compounds and their uses in therapy - Google Patents

Bicyclic heterocycle compounds and their uses in therapy

Info

Publication number
GB201406986D0
GB201406986D0 GB201406986A GB201406986A GB201406986D0 GB 201406986 D0 GB201406986 D0 GB 201406986D0 GB 201406986 A GB201406986 A GB 201406986A GB 201406986 A GB201406986 A GB 201406986A GB 201406986 D0 GB201406986 D0 GB 201406986D0
Authority
GB
United Kingdom
Prior art keywords
therapy
bicyclic heterocycle
heterocycle compounds
compounds
bicyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201406986A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astex Therapeutics Ltd
Original Assignee
Astex Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astex Therapeutics Ltd filed Critical Astex Therapeutics Ltd
Priority to GB201406986A priority Critical patent/GB201406986D0/en
Publication of GB201406986D0 publication Critical patent/GB201406986D0/en
Priority to RS20211096A priority patent/RS62301B1/en
Priority to US15/105,360 priority patent/US9783538B2/en
Priority to NZ71990514A priority patent/NZ719905A/en
Priority to MYPI2020002540A priority patent/MY193649A/en
Priority to BR122022015241-4A priority patent/BR122022015241B1/en
Priority to HUE14815838A priority patent/HUE056297T2/en
Priority to LTEPPCT/GB2014/053778T priority patent/LT3083616T/en
Priority to PL14815838T priority patent/PL3083616T3/en
Priority to DK14815838.9T priority patent/DK3083616T3/en
Priority to KR1020167019182A priority patent/KR102408262B1/en
Priority to SG10201808102WA priority patent/SG10201808102WA/en
Priority to JP2016541373A priority patent/JP6470756B2/en
Priority to TW103144450A priority patent/TWI649319B/en
Priority to EP14815838.9A priority patent/EP3083616B1/en
Priority to PT148158389T priority patent/PT3083616T/en
Priority to RU2016129472A priority patent/RU2696310C1/en
Priority to CN202210613741.1A priority patent/CN115368356A/en
Priority to AU2014369446A priority patent/AU2014369446C1/en
Priority to MYPI2016701668A priority patent/MY186311A/en
Priority to BR112016014561-5A priority patent/BR112016014561B1/en
Priority to PCT/GB2014/053778 priority patent/WO2015092420A1/en
Priority to NZ758528A priority patent/NZ758528A/en
Priority to CA2933939A priority patent/CA2933939C/en
Priority to SI201431877T priority patent/SI3083616T1/en
Priority to MX2016008131A priority patent/MX2016008131A/en
Priority to SG11201604795RA priority patent/SG11201604795RA/en
Priority to CN201811129977.8A priority patent/CN109336883B/en
Priority to EP19219371.2A priority patent/EP3686200A3/en
Priority to ES14815838T priority patent/ES2883289T3/en
Priority to CN201480069940.4A priority patent/CN105829310B/en
Priority to PH12016501139A priority patent/PH12016501139B1/en
Priority to IL246239A priority patent/IL246239B/en
Priority to SA516371360A priority patent/SA516371360B1/en
Priority to US15/675,052 priority patent/US10618895B2/en
Priority to JP2019005876A priority patent/JP6735369B2/en
Priority to AU2019200840A priority patent/AU2019200840C1/en
Priority to US16/795,117 priority patent/US11225476B2/en
Priority to JP2020119260A priority patent/JP7110279B2/en
Priority to CY20211100729T priority patent/CY1124436T1/en
Priority to HRP20211406TT priority patent/HRP20211406T1/en
Priority to US17/643,083 priority patent/US11643410B2/en
Priority to US18/069,571 priority patent/US20230227450A1/en
Ceased legal-status Critical Current

Links

GB201406986A 2013-12-20 2014-04-17 Bicyclic heterocycle compounds and their uses in therapy Ceased GB201406986D0 (en)

Priority Applications (43)

Application Number Priority Date Filing Date Title
GB201406986A GB201406986D0 (en) 2014-04-17 2014-04-17 Bicyclic heterocycle compounds and their uses in therapy
PCT/GB2014/053778 WO2015092420A1 (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
BR112016014561-5A BR112016014561B1 (en) 2013-12-20 2014-12-19 BICYCLIC HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, THEIR USES FOR THE PROPHYLAXIS OR TREATMENT OF CANCER AND PROCESS FOR PREPARING SAID COMPOUNDS
NZ758528A NZ758528A (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
NZ71990514A NZ719905A (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
US15/105,360 US9783538B2 (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
BR122022015241-4A BR122022015241B1 (en) 2013-12-20 2014-12-19 INTERMEDIATE BICYCLIC HETEROCYCLIC COMPOUNDS FOR THE PREPARATION OF A COMPOUND OF FORMULA (I)
HUE14815838A HUE056297T2 (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
LTEPPCT/GB2014/053778T LT3083616T (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
PL14815838T PL3083616T3 (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
DK14815838.9T DK3083616T3 (en) 2013-12-20 2014-12-19 BICYCLIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS IN THERAPY
KR1020167019182A KR102408262B1 (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
SG10201808102WA SG10201808102WA (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
JP2016541373A JP6470756B2 (en) 2013-12-20 2014-12-19 Bicyclic heterocyclic compounds and their use in therapy
TW103144450A TWI649319B (en) 2013-12-20 2014-12-19 Bicyclic heterocyclic compounds and therapeutic uses thereof
EP14815838.9A EP3083616B1 (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
PT148158389T PT3083616T (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
CA2933939A CA2933939C (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
CN202210613741.1A CN115368356A (en) 2013-12-20 2014-12-19 Bicyclic heterocyclic compounds and their therapeutic use
AU2014369446A AU2014369446C1 (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
MYPI2016701668A MY186311A (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
RS20211096A RS62301B1 (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
CN201480069940.4A CN105829310B (en) 2013-12-20 2014-12-19 Bicyclic heterocycles and its therapeutical uses
MYPI2020002540A MY193649A (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
RU2016129472A RU2696310C1 (en) 2013-12-20 2014-12-19 Bicyclic heterocyclic compounds and use thereof in therapy
SI201431877T SI3083616T1 (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
MX2016008131A MX2016008131A (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy.
SG11201604795RA SG11201604795RA (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
CN201811129977.8A CN109336883B (en) 2013-12-20 2014-12-19 Bicyclic heterocyclic compounds and their therapeutic use
EP19219371.2A EP3686200A3 (en) 2013-12-20 2014-12-19 Bicyclic heterocycle compounds and their uses in therapy
ES14815838T ES2883289T3 (en) 2013-12-20 2014-12-19 Bicyclic heterocyclic compounds and their uses in therapy
PH12016501139A PH12016501139B1 (en) 2013-12-20 2016-06-13 Bicyclic heterocycle compounds and their uses in therapy
IL246239A IL246239B (en) 2013-12-20 2016-06-15 Bicyclic heterocycle compounds and their uses in therapy
SA516371360A SA516371360B1 (en) 2013-12-20 2016-06-19 Bicyclic heterocycle compounds and their uses in therapy
US15/675,052 US10618895B2 (en) 2013-12-20 2017-08-11 Bicyclic heterocycle compounds and their uses in therapy
JP2019005876A JP6735369B2 (en) 2013-12-20 2019-01-17 Bicyclic heterocyclic compounds and their use in therapy
AU2019200840A AU2019200840C1 (en) 2013-12-20 2019-02-07 Bicyclic heterocycle compounds and their uses in therapy
US16/795,117 US11225476B2 (en) 2013-12-20 2020-02-19 Bicyclic heterocycle compounds and their uses in therapy
JP2020119260A JP7110279B2 (en) 2013-12-20 2020-07-10 Bicyclic heterocyclic compounds and their use in therapy
CY20211100729T CY1124436T1 (en) 2013-12-20 2021-08-12 BICYCLIC HETEROCYCLIC COMPOUNDS AND THERAPEUTIC USES THEREOF
HRP20211406TT HRP20211406T1 (en) 2013-12-20 2021-09-03 Bicyclic heterocycle compounds and their uses in therapy
US17/643,083 US11643410B2 (en) 2013-12-20 2021-12-07 Bicyclic heterocycle compounds and their uses in therapy
US18/069,571 US20230227450A1 (en) 2013-12-20 2022-12-21 Bicyclic heterocycle compounds and their uses in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201406986A GB201406986D0 (en) 2014-04-17 2014-04-17 Bicyclic heterocycle compounds and their uses in therapy

Publications (1)

Publication Number Publication Date
GB201406986D0 true GB201406986D0 (en) 2014-06-04

Family

ID=50928954

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201406986A Ceased GB201406986D0 (en) 2013-12-20 2014-04-17 Bicyclic heterocycle compounds and their uses in therapy

Country Status (1)

Country Link
GB (1) GB201406986D0 (en)

Similar Documents

Publication Publication Date Title
HK1243073A1 (en) Therapeutic compounds and uses thereof
IL246239A0 (en) Bicyclic heterocycle compounds and their uses in therapy
GB201403093D0 (en) Therapeutic compounds and their use
IL251630A0 (en) Combination therapy for use in cancer therapy
GB201404470D0 (en) Therapeutic methods and materials
IL251371A0 (en) Cortexolone 17alpha-benzoate for use in the treatment of tumours
IL276733A (en) Use of eribulin in the treatment of cancer
GB201511382D0 (en) Novel compounds and their use in therapy
IL251904A0 (en) Apilimod for use in the treatment of melanoma
IL247325A0 (en) Therapeutic methods employing noribogaine and related compounds
GB201406172D0 (en) Therapy and pharmaceutical composition
GB201418809D0 (en) Therapeutic agents and uses thereof
GB201409653D0 (en) Pyrrolobenzodiazepine therapeutic agents
GB201418541D0 (en) Materials for use with general hyperthermia treatment
GB201406986D0 (en) Bicyclic heterocycle compounds and their uses in therapy
GB201409978D0 (en) Novel compounds and their use in therapy
GB201410387D0 (en) Compounds and their therapeutic use
GB201403496D0 (en) Compounds and their therapeutic use
GB201322755D0 (en) Bicyclic heterocycle compounds and their uses in therapy
GB201416493D0 (en) Polypeptides for use in therapy
GB201410695D0 (en) Uses of oligouronates in cancer treatment
GB201417777D0 (en) Novel compounds and therapeutic uses thereof
GB201412285D0 (en) Therapeutic treatments
GB201412293D0 (en) Therapeutic treatments
GB201411111D0 (en) bis-Pyridazine compounds and their use in treating cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)